These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15848655)

  • 21. Survival after pediatric liver transplantation: why does living donation offer an advantage?
    Austin MT; Feurer ID; Chari RS; Gorden DL; Wright JK; Pinson CW
    Arch Surg; 2005 May; 140(5):465-70; discussion 470-1. PubMed ID: 15897442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation.
    Gaynor JJ; Moon JI; Kato T; Nishida S; Selvaggi G; Levi DM; Island ER; Pyrsopoulos N; Weppler D; Ganz S; Ruiz P; Tzakis AG
    Transplantation; 2007 Jul; 84(2):155-65. PubMed ID: 17667806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matching donors and recipients.
    Marino IR; Doria C; Doyle HR; Gayowski TJ
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S115-9. PubMed ID: 9742504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a model predicting graft survival after liver transplantation.
    Ioannou GN
    Liver Transpl; 2006 Nov; 12(11):1594-606. PubMed ID: 16952176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
    El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matching donor to recipient in lung transplantation: How much does size matter?
    Mason DP; Batizy LH; Wu J; Nowicki ER; Murthy SC; McNeill AM; Budev MM; Mehta AC; Pettersson GB; Blackstone EH
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1234-40.e1. PubMed ID: 19379997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predisposing factors for ureteric strictures in renal transplantation].
    Hétet JF; Rigaud J; Gignoux A; Le Normand L; Glémain P; Bouchot O; Karam G
    Prog Urol; 2005 Jun; 15(3):462-71. PubMed ID: 16097152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of pre-emptive re-transplant in graft and recipient outcome.
    Goldfarb-Rumyantzev AS; Hurdle JF; Baird BC; Stoddard G; Wang Z; Scandling JD; Barenbaum LL; Cheung AK
    Nephrol Dial Transplant; 2006 May; 21(5):1355-64. PubMed ID: 16476722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft survival and its determinants: a 3 year national experience with liver transplantation in Israel.
    Ekka-Zohar A; Zitser-Gurevich Y; Mandel M; Weiss-Salz I; Nir S; Mor E; Richard N; Merhav H; Bruck R; Simchen E
    Isr Med Assoc J; 2006 Jun; 8(6):400-5. PubMed ID: 16833169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database.
    Russo MJ; Chen JM; Sorabella RA; Martens TP; Garrido M; Davies RR; George I; Cheema FH; Mosca RS; Mital S; Ascheim DD; Argenziano M; Stewart AS; Oz MC; Naka Y
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):554-9. PubMed ID: 17258599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis.
    Stewart ZA; Locke JE; Montgomery RA; Singer AL; Cameron AM; Segev DL
    Liver Transpl; 2009 Aug; 15(8):883-93. PubMed ID: 19642117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
    Kaczmarek I; Deutsch MA; Rohrer ME; Beiras-Fernandez A; Groetzner J; Daebritz S; Schmoeckel M; Spannagl M; Meiser B; Reichart B
    J Heart Lung Transplant; 2006 Sep; 25(9):1057-62. PubMed ID: 16962466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I; McShane P; Koo DD; Gray D; Friend PJ; Fuggle S; Darby C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.